Physician profile
Daniel Tresley
NPI 1831182468
$1,551.78
in general payments reported to CMS, 2019-2025
12 companies · $47.15 in 2025
The $47.15 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $52.33 · 2021: $252 · 2022: $360 · 2023: $310 · 2024: $259 · 2025: $47.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574 · Education: $42.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.56 |
| Education | $42.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $302.23 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $293.79 | 2022-2023 | Seglentis |
| Abbvie INC. | $270.58 | 2023-2025 | Botox |
| Galderma Laboratories, L.P. | $232.58 | 2019-2024 | Dysport |
| Horizon Therapeutics Plc | $197.52 | 2021-2022 | |
| Biotissue Holdings INC. | $107.98 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $43.02 | 2020-2022 | |
| Merz North America, INC. | $26.61 | 2023 | Xeomin |
| Mallinckrodt Hospital Products INC. | $22.98 | 2022 | |
| Organogenesis INC. | $19.16 | 2023 | Puraply |
| Ethicon US, LLC | $17.92 | 2022 | |
| Thea Pharma INC. | $17.41 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Tresley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.